Literature DB >> 18443747

Purinergic receptors in the splanchnic circulation.

Manuela Morato1, Teresa Sousa, António Albino-Teixeira.   

Abstract

There is considerable evidence that purines are vasoactive molecules involved in the regulation of blood flow. Adenosine is a well known vasodilator that also acts as a modulator of the response to other vasoactive substances. Adenosine exerts its effects by interacting with adenosine receptors. These are metabotropic G-protein coupled receptors and include four subtypes, A(1), A(2A), A(2B) and A(3). Adenosine triphosphate (ATP) is a co-transmitter in vascular neuroeffector junctions and is known to activate two distinct types of P2 receptors, P2X (ionotropic) and P2Y (metabotropic). ATP can exert either vasoconstrictive or vasorelaxant effects, depending on the P2 receptor subtype involved. Splanchnic vascular beds are of particular interest, as they receive a large fraction of the cardiac output. This review focus on purinergic receptors role in the splanchnic vasomotor control. Here, we give an overview on the distribution and diversity of effects of purinergic receptors in splanchnic vessels. Pre- and post-junctional receptormediated responses are summarized. Attention is also given to the interactions between purinergic receptors and other receptors in the splanchnic circulation.

Entities:  

Year:  2008        PMID: 18443747      PMCID: PMC2486341          DOI: 10.1007/s11302-008-9096-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  189 in total

1.  Purinergic receptors.

Authors:  G Burnstock
Journal:  J Theor Biol       Date:  1976-10-21       Impact factor: 2.691

Review 2.  Signaling by extracellular nucleotides.

Authors:  A J Brake; D Julius
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

3.  Characterization of prejunctional purinoceptors inhibiting noradrenaline release in rat mesenteric arteries.

Authors:  K Shinozuka; Y Tanioka; Y M Kwon; N Tanaka; Y Kubota; K Nakamura; M Kunitomo
Journal:  Jpn J Pharmacol       Date:  2001-01

4.  P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.

Authors:  A Nicke; H G Bäumert; J Rettinger; A Eichele; G Lambrecht; E Mutschler; G Schmalzing
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

5.  Activation of mesenteric arteries and veins by preganglionic and postganglionic nerves.

Authors:  D L Kreulen
Journal:  Am J Physiol       Date:  1986-12

6.  Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats.

Authors:  Y Kamikawa; W H Cline; C Su
Journal:  Eur J Pharmacol       Date:  1980-09-05       Impact factor: 4.432

7.  P2X1 receptors mediate sympathetic postjunctional Ca2+ transients in mesenteric small arteries.

Authors:  Christine Lamont; C Vial; R J Evans; W G Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-08-18       Impact factor: 4.733

8.  Relaxant effect of 2-methyl-thio-adenosine diphosphate on rat thoracic aorta: effect of clopidogrel.

Authors:  F Dol-Gleizes; A M Marés; P Savi; J M Herbert
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

9.  Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters.

Authors:  P Sneddon; G Burnstock
Journal:  Eur J Pharmacol       Date:  1984-04-13       Impact factor: 4.432

10.  Prejunctional opioid mu-receptors and adenosine A1-receptors on the sympathetic nerve endings of the rat tail artery interact with the alpha 2-adrenoceptors.

Authors:  B Bucher; C Corriu; J C Stoclet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

View more
  1 in total

1.  Splenic switch-off as a novel marker for adenosine response in nitrogen-13 ammonia PET myocardial perfusion imaging: Cross-validation against CMR using a hybrid PET/MR device.

Authors:  Ronny R Buechel; Tobias A Fuchs; Adam Bakula; Dimitri Patriki; Elia von Felten; Georgios Benetos; Aleksandra Sustar; Dominik C Benz; Muriel Wiedemann-Buser; Valerie Treyer; Aju P Pazhenkottil; Christoph Gräni; Catherine Gebhard; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2020-12-22       Impact factor: 3.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.